Your Questions, My Thoughts: Navigating the PV Landscape
The inbox at MediPharmSolutions has been buzzing lately. From students finishing their certifications to seasoned professionals looking for a pivot, the "Mentor Circle" is alive with curiosity. Pharmacovigilance (PV) is more than just data entry; it’s the heartbeat of patient safety.
To showcase some of the questions answered in the past week, I thought it will be a great value to wider audience to share them in this series every week. Of course to protect the identity of the person asking the questions, their names have been changed.
Here are the top five stories and questions from this week’s mentorship sessions from MediPharmSolutions:
1. The Bridge from Theory to Practice
The Story: Radhika who is a Pharmacist reached out, feeling overwhelmed by the technical jargon of E2B standards. They understood "safety," but "transmission protocols" felt like a different language.
- The Question: "Is it more important to know the science of the drug or the technical standards like E2B R3?"
- The Thought: You need both. While the medical assessment is the soul of a case, technical standards like ICSR E2B R3 are the skeleton that allows that data to move globally. Think of R3 as the upgraded language that allows for more precise, structured data sharing compared to the older R2 version. Mastery of the "how" (the standard) makes your "what" (the safety data) impactful.
2. The Career Pivoter
The Story: Ammy who is a clinical research associate with five years of experience felt they had hit a ceiling and wanted to move into PV.
- The Question: "How do I show I’m ready for a career in PV?"
- The Thought: Focus on upskilling in PV. Your experience monitoring sites as a CRA has already trained you in clinical trial management. In PV, we can utilise those insights and upskill to translate your clinical oversight into proactive safety surveillance.
3. The "Entry-Level" Dilemma
The Story: A recent graduate was frustrated by job postings requiring 2 years of experience in PV.
- The Question: "How do I get experience if no one will hire me without it?"
- The Thought: Don't just wait for a job; build a portfolio of knowledge. Understand the nuances of the ICSR (Individual Case Safety Report) process. Use LinkedIn to discuss recent FDA or EMA safety updates. Network with PV professionals, look for opportunities within the companies such as CROs and/or Non profit research foundations that requires asssitance with daily PV Operations. Do not filter jobs based on your convenience. get your foot in the door first before eliminating your choices. you stop looking like a novice and start looking like a specialist.
4. The Quality Specialist
The Story: A PV professional working in Quality Assurance (QA) was worried that automation and AI would make their role redundant.
- The Question: "Will AI replace the need for human narrative writing in PV?"
- The Thought: AI will handle the transcription, but humans provide the interpretation. Automation is excellent at moving data, but it cannot yet replicate the "gut feeling" or the complex causality assessment required for a serious adverse event. Your role is evolving from "writer" to "editor and strategist."
5. The Global Visionary
The Story: A professional in a local pharmaceutical firm wanted to know how to "go global" and work for a major Multinational Corporation (MNC).
- The Question: "What is the single most important skill for a global PV career?"
- The Thought: Adaptability to Global Standards. Regulations aren't static. Professionals who stay ahead of these regulatory shifts and understand how they improve patient safety across borders are the ones who become indispensable to global teams.
What’s on your mind?
Whether you are curious about pharmacovigilance Jobs or career growth, drop your questions in the comments or send a DM.
Let’s keep the circle growing.
#Pharmacovigilance #MentorCircle #MediPharmSolutions #PatientSafety #CareerAdvice
To learn more from related topics, please visit our website or newsletter at https://medipharmsolutions.com/newsletter/
No Comments